Special Issue "Marine Photoprotective Compounds"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 December 2009)

Special Issue Editor

Guest Editor
Dr. Manfred Klisch
Plant Ecophysiology, Department of Biology, Friedrich-Alexander University, Erlangen, Germany
E-Mail: mklisch@biologie.uni-erlangen.de
Interests: ecophysiology of algae and cyanobacteria; biochemical adaptations to environmental stress

Special Issue Information

Dear Colleagues,

Marine organisms of the photic zone have evolved a variety of defense strategies against the adverse effects of solar radiation. These include screening of the ultraviolet proportions of the solar spectrum, quenching of photochemically generated radicals and repair of photodamage. Apart from carotenoids the mycosporine-like amino acids (MAAs) are among the most prominent examples of marine photoprotective compounds. These strong UV-absorbers have gained continuing scientific attention over the last decades. The increasing public concern regarding possible adverse effects of synthetic sunscreens underlines the necessity of natural alternatives and adjuvants. Therefore MAAs have attained particular commercial interest in the recent years. The current special issue will present a selection of research papers and reviews on the different aspects of marine photoprotective compounds. These can be original research articles as well as review papers related to marine photoprotective compounds. The focus of the papers may range from physiological and biochemical aspects to possible applications.

Manfred Klisch, Ph. D.
Guest Editor

Keywords

  • carotenoids
  • mycosporine-like amino acids
  • scytonemin; photoprotective compounds
  • ultraviolet radiation
  • reactive oxygen species

Published Papers (5 papers)

Mar. Drugs 2011, 9(3), 387-446; doi:10.3390/md9030387
Received: 25 January 2011; in revised form: 18 February 2011 / Accepted: 9 March 2011 / Published: 21 March 2011
Show/Hide Abstract | Download PDF Full-text (2947 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2010, 8(5), 1681-1698; doi:10.3390/md8051681
Received: 22 April 2010; in revised form: 12 May 2010 / Accepted: 21 May 2010 / Published: 25 May 2010
Show/Hide Abstract | Download PDF Full-text (412 KB) | View HTML Full-text | Download XML Full-text
abstract graphic

Mar. Drugs 2010, 8(4), 1273-1291; doi:10.3390/md8041273
Received: 8 March 2010; in revised form: 9 April 2010 / Accepted: 13 April 2010 / Published: 16 April 2010
Show/Hide Abstract | Download PDF Full-text (217 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2010, 8(4), 1189-1202; doi:10.3390/md8041189
Received: 22 February 2010; in revised form: 30 March 2010 / Accepted: 7 April 2010 / Published: 8 April 2010
Show/Hide Abstract | Download PDF Full-text (244 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2010, 8(1), 106-121; doi:10.3390/md8010106
Received: 4 December 2009; in revised form: 5 January 2010 / Accepted: 19 January 2010 / Published: 20 January 2010
Show/Hide Abstract | Download PDF Full-text (219 KB) | View HTML Full-text | Download XML Full-text
abstract graphic

Last update: 27 February 2014

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert